These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 12201846)

  • 1. Immunological characterization of anti-Mi(a), a red blood cell alloantibody, in Taiwan.
    Lo SC; Chang JS; Lin SW; Lin DT
    Vox Sang; 2002 Aug; 83(2):162-4. PubMed ID: 12201846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence and significance of anti-"Mia" in Taiwan.
    Broadberry RE; Lin M
    Transfusion; 1994 Apr; 34(4):349-52. PubMed ID: 8178333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A survey of the incidence of Miltenberger antibodies among Hong Kong Chinese blood donors.
    Mak KH; Banks JA; Lubenko A; Chua KM; Torres de Jardine AL; Yan KF
    Transfusion; 1994 Mar; 34(3):238-41. PubMed ID: 8146897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discrepant in vitro versus in vivo interaction of M-positive donor red cells with IgG1 anti-M.
    Branch DR; McBroom R; Jones GL
    Rev Fr Transfus Immunohematol; 1983 Dec; 26(6):565-72. PubMed ID: 6675157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemolytic disease of the newborn due to anti-M.
    Duguid JK; Bromilow IM; Entwistle GD; Wilkinson R
    Vox Sang; 1995; 68(3):195-6. PubMed ID: 7625079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic disease of the newborn due to anti-U.
    Novaretti MC; Jens E; Pagliarini T; Bonif cio Sle O; Dorlhiac-Llacer PE; Chamone Dd Dde A
    Rev Hosp Clin Fac Med Sao Paulo; 2003; 58(6):320-3. PubMed ID: 14762491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of GP. Mur antigen-negative RBC for blood recipients with anti-'Mi
    Yang CA; Lin JA; Chang CW; Wu KH; Yeh SP; Ho CM; Chang JG
    Transfus Med; 2016 Oct; 26(5):349-354. PubMed ID: 27634577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of transfusion needs in a case of immunizing anti-M antibody in a patient with acute myeloid leukemia.
    Navkudkar A; Desai P; Thakkar R; Rajadhyaksha S
    Indian J Pathol Microbiol; 2020; 63(2):251-254. PubMed ID: 32317525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MNSs blood group glycophorin variants in Taiwan: a genotype-serotype correlation study of 'Mi(a)' and St(a) with report of two new alleles for St(a).
    Chen TD; Chen DP; Wang WT; Sun CF
    PLoS One; 2014; 9(5):e98166. PubMed ID: 24858913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro functional activity of IgG1 and IgG3 polyclonal and monoclonal anti-D.
    Kumpel BM
    Vox Sang; 1997; 72(1):45-51. PubMed ID: 9031501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of an antibody causing agglutination of M-positive non-enzymatically glycosylated human red cells.
    Reid ME; Ellisor SS; Barker JM; Lewis T; Avoy DR
    Vox Sang; 1981; 41(2):85-90. PubMed ID: 7331284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrops foetalis caused by anti-Mur in first pregnancy--a case report.
    Wu KH; Chang JG; Lin M; Shih MC; Lin H; Lee CC; Peng CT; Tsai CH
    Transfus Med; 2002 Oct; 12(5):325-7. PubMed ID: 12383339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of antibodies produced by S-s- individuals.
    Storry JR; Reid ME
    Transfusion; 1996 Jun; 36(6):512-6. PubMed ID: 8669082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of complement binding by anti-D and anti-M antibodies employing labelled antiglobulin antibodies.
    Freedman J; Massey A; Chaplin H; Monroe MC
    Br J Haematol; 1980 Jun; 45(2):309-18. PubMed ID: 6776980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A retrospective study of red cell maternal antibodies by chemiluminescence.
    Downing I; Bromilow IM; Templeton JG; Fraser RH
    Vox Sang; 1996; 71(4):226-32. PubMed ID: 8958647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fc-Glycosylation in Human IgG1 and IgG3 Is Similar for Both Total and Anti-Red-Blood Cell Anti-K Antibodies.
    Sonneveld ME; Koeleman CAM; Plomp HR; Wuhrer M; van der Schoot CE; Vidarsson G
    Front Immunol; 2018; 9():129. PubMed ID: 29445378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-U-like as an alloantibody in S-s-U- and S-s-U+(var) black people.
    Peyrard T; Lam Y; Saison C; Arnaud L; Babinet J; Rouger P; Bierling P; Janvier D
    Transfusion; 2012 Mar; 52(3):622-8. PubMed ID: 21880045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delayed haemolytic transfusion reaction due to anti-M antibody.
    Sancho JM; Pujol M; Fernández F; Soler M; Manzano P; Feliu E
    Br J Haematol; 1998 Oct; 103(1):268-9. PubMed ID: 9792320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-E Detected in a 7-Month-Old Infant with Acute Lymphoblastic Leukemia after Transfusion.
    Kumeta M; Tanaka K; Kaneko N; Osanai T; Ajima H; Tamai Y; Kayaba H; Ito E; Saito N
    Clin Lab; 2018 Jun; 64(6):1079-1082. PubMed ID: 29945333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses.
    Wasowska B; Baldwin WM; Howell DN; Sanfilippo F
    Transplantation; 1993 Sep; 56(3):672-80. PubMed ID: 7692630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.